Growing prevalence of respiratory problems is expected to drive the growth of India azithromycin market.
According to TechSci Research report, “India Azithromycin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Powder, Solution/Drops), By Route of Administration (Oral, Injectable, Ophthalmic), By Distribution Channel (Online v/s Offline), By Application (Middle Ear Infections, Strep Throat, Pneumonia, Travelers Diarrhea, Sexually Transmitted Infections, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026”, the India azithromycin market is expected to grow at a steady rate during the forecast period on account of the growing prevalence of bacterial infections. Azithromycin is an antibacterial antibiotic which functions by stopping the synthesis of important proteins that are required for the growth of bacteria and are essential for it to carry out vital functions inside the human body. In this way, the drug prevents bacterial growth and infection spread across the body. The drug has a long serum half-life and is able to resist several bacteria, even those belonging to the streptococcus family. Azithromycin is used in combination with the anti-malarial drug hydroxychloroquine for the treatment of patients suffering from COVID-19. This in turn is expected to fuel the market growth through FY2026. Besides, the drug is helpful in fighting a range of respiratory infections including mild to moderate lung infections, sinuses, pneumonia, among others. However, side-effects associated with drug consumption such as nausea, vomiting, abdominal pain, diarrhea and stomach infection can restrict the market growth over the next few years. This can further reduce the usage and application of the drug thereby hindering the market growth.
Browse XX market data Tables and XX Figures spread through XX Pages and an in-depth TOC on “India azithromycin market “
https://www.techsciresearch.com/report/india-azithromycin-market/5138.html
The India azithromycin market is segmented based on source, form, route of administration, distribution channel, application, end user, company and region. Based on form, the market can be fragmented into tablets, powder and solution/drops. The tablets segment is expected to dominate the market on account of their self-administration, patient compliance and cost-effectiveness. Based on route of administration, the market can be categorized into oral, injectable and ophthalmic. The oral route is expected to dominate the market since this is the simplest, pain free and easy to take route of drug administration. Additionally, when a drug is taken orally the absorption takes place along the complete length of gastrointestinal tract.
Pfizer Limited, Lupin Limited, Aurobindo Pharma Limited, Alembic Pharmaceuticals, Jubilant Life Sciences Limited, Sandoz Private Limited, Century Pharmaceuticals Limited, Infinity Laboratories Pvt. Ltd., Anuh Pharma Ltd., Farmachem Life Pvt Ltd., Envee Drugs Pvt. Ltd. and others are some of the leading players operating in India azithromycin market. Companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5138
Customers can also request for 10% free customization on this report.
“India azithromycin market is expected to witness growth during the forecast period on account of the Pharma Vision 2020 announced by the government of India. With the goal of making India a global leader in not only generic medicine production but also an end to end leader in drug discovery and development this vision was put forth. Furthermore, the China plus one strategy to stop dependency on imports from China and making investments in China for drugs, intermediates and APIs is further expected to fuel the market growth through FY2026. Also, various schemes were launched to promote drug development and discovery indigenously through the network of local manufacturers amidst the Indo-China border escalations and COVID-19 which are further expected to create lucrative opportunities for the market growth over the next five years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.
“India Azithromycin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Powder, Solution/Drops), By Route of Administration (Oral, Injectable, Ophthalmic), By Distribution Channel (Online v/s Offline), By Application (Middle Ear Infections, Strep Throat, Pneumonia, Travelers Diarrhea, Sexually Transmitted Infections, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India azithromycin market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in India azithromycin market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]